Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Bicalutamide
Related Products

Hot Products

Basic Information Post buying leads Suppliers Cas Database
Name

Bicalutamide

 EINECS N/A
CAS No. 90357-06-5 Density 1.52 g/cm3
PSA 115.64000 LogP 4.03338
Solubility Insoluble in water Melting Point 191-193 °C
Formula C18H14F4N2O4S Boiling Point 650.3 °C at 760 mmHg
Molecular Weight 430.38 Flash Point 347.1 °C
Transport Information N/A Appearance off-white crystalline solid
Safety 26-36 Risk Codes 36/37/38
Molecular Structure Molecular Structure of 90357-06-5 (Bicalutamide) Hazard Symbols IrritantXi
Synonyms

(2S)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide;Casodex;Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-;Bicalutamide (JAN/USP);Casodex (TN);(±)-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-methyl-[(4- fluorophenyl) sulfonyl]-2-hydroxy- 2-methyl propanamide;N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide;Bicalutamide [USAN:BAN:INN];ICI 176334;Propanamide,N-[4-cyano-3-(trifluoromethyl)- phenyl]-3-[(4-fluorophenyl)sulfonyl]-2- hydroxy-2-methyl-;

Article Data 51

Bicalutamide Synthetic route

90356-78-8

N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
Stage #1: N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide With potassium permanganate; tetra(n-butyl)ammonium hydrogensulfate In water; ethyl acetate at 25 - 30℃; for 2.5h;
Stage #2: With sodium metabisulfite In water; ethyl acetate for 1h;		100%
With (dimethyl dioctadecylammonium)3[PW12O40]; dihydrogen peroxide In dichloromethane at 25℃; for 0.416667h; Catalytic behavior; Temperature; Reagent/catalyst;99.1%
Stage #1: N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide With dihydrogen peroxide; sodium tungstate; methanesulfonic acid In water; ethyl acetate at 25 - 32℃; for 6h;
Stage #2: With sodium thiosulfate In water; ethyl acetate for 0.5h; Product distribution / selectivity;		98%
371-42-6

4-Fluorothiophenol

90357-51-0

N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
Stage #1: 4-Fluorothiophenol; N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide With sodium hydroxide; tetra(n-butyl)ammonium hydrogensulfate In water; ethyl acetate at 25 - 30℃; for 3h;
Stage #2: With potassium permanganate In water; ethyl acetate for 2.5h;
Stage #3: With sodium metabisulfite In water; ethyl acetate at 50℃; for 1h; Product distribution / selectivity;		97.3%
90356-78-8

N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide

A

945419-64-7

N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfinyl-2-hydroxy-2-methyl-propanamide

B

90357-06-5

Bicalutamide

Conditions
ConditionsYield
With urea hydrogen peroxide adduct In tetrahydrofuran; formic acid; water at 27 - 35℃; for 1h;A 0.08 %Chromat.
B 96%
455-15-2

1-(methylsufonyl)-4-fluorobenzene

87310-69-8

N-(4-cyano-3-(trifluoromethyl)phenyl)-2-oxo propanamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
Stage #1: 1-(methylsufonyl)-4-fluorobenzene With n-butyllithium In tetrahydrofuran at -78℃; for 0.333333h;
Stage #2: N-(4-cyano-3-trifluoromethyl-phenyl)-2-oxo-propionamide In tetrahydrofuran at -78 - 20℃; Further stages.;		95%
Stage #1: 1-(methylsufonyl)-4-fluorobenzene With n-butyllithium In tetrahydrofuran for 1h;
Stage #2: N-(4-cyano-3-trifluoromethyl-phenyl)-2-oxo-propionamide In tetrahydrofuran for 0.333333h;		90%
With n-butyllithium In tetrahydrofuran1.67 g (90%)
937-14-4

3-chloro-benzenecarboperoxoic acid

90356-78-8

N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfanyl]-2-hydroxy-2-methylpropanamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
In dichloromethane94%

(((tert-butyldimethylsilyl)oxy)methyl)(4-fluorophenyl)sulfone

90357-51-0

N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
With cesium fluoride In water at 90℃; for 15h;93%
With cesium fluoride In water at 90℃; for 15h; Inert atmosphere;93%
371-42-6

4-Fluorothiophenol

90357-53-2

N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methylacrylamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
Stage #1: 4-Fluorothiophenol; N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methylacrylamide With oxygen In acetonitrile at 45℃; for 10h;
Stage #2: With oxone In acetonitrile for 18h; Temperature; Reagent/catalyst;		88%
Stage #1: 4-Fluorothiophenol; N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methylacrylamide With oxygen In ethanol at 45℃; Green chemistry;
Stage #2: With Oxone In ethanol at 45℃; Green chemistry;		68%
1067225-62-0

4-cyano-3-(trifluoromethyl)phenylisocyanide

432-98-4

1-(4-fluorophenylsulfonyl)propan-2-one

90357-06-5

Bicalutamide

Conditions
ConditionsYield
Stage #1: 4-cyano-3-(trifluoromethyl)phenylisocyanide With titanium tetrachloride In dichloromethane for 1h; Passerini reaction; Cooling with ice;
Stage #2: 1-(4-fluorophenylsulfonyl)propan-2-one In dichloromethane for 3h; Passerini reaction;
Stage #3: With water In dichloromethane for 0.333333h;		66%
824-80-6

sodium 4-fluorobenzenesulfinate

90357-51-0

N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide

90357-06-5

Bicalutamide

Conditions
ConditionsYield
With tetrabutylammomium bromide In chloroform; water for 96h; Heating / reflux;48%
With sulfuric acid In ethanol for 6h; Heating / reflux;
216665-25-7

N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-3-iodo-2-methylpropanamide

824-80-6

sodium 4-fluorobenzenesulfinate

90357-06-5

Bicalutamide

Conditions
ConditionsYield
In dimethyl sulfoxide at 60℃; for 8h;23%

Bicalutamide Standards and Recommendations

 Bicalutamide (CAS NO.90357-06-5) is preventing the activation of the AR and acts as a pure anti-androgen by binding to the androgen receptor (AR) and subsequent upregulation of androgen responsive genes by androgenic hormones. In addition, bicalutamide accelerates the degradation of the androgen receptor.

Bicalutamide Specification

1. Introduction of Bicalutamide
Bicalutamide is one kind of off-white crystalline solid. Bicalutamide is practically insoluble in water. The Product Categories of this chemical is Active Pharmaceutical Ingredients;Antiandrogen;Antineoplastic (Hormonal);anti-neoplastic;Aromatics;Intermediates & Fine Chemicals;Pharmaceuticals;Sulfur & Selenium Compounds;API's. The Classification Code of Bicalutamide is Androgen antagonists; Antineoplastic; Antineoplastic agents; Drug / Therapeutic Agent; Hormone Antagonists; Hormones, Hormone Substitutes, and Hormone Antagonists; Reproductive Effect.

2. Properties of Bicalutamide
Physical properties about Bicalutamide are:
(1)XLogP3-AA: 2.3; (2)H-Bond Donor: 2; (3)H-Bond Acceptor: 9; (4)Melting Point: 191-193 °C; (5)Surface Tension: 58.2 dyne/cm; (6)Density: 1.52 g/cm3; (7)Flash Point: 347.1 °C; (8)Enthalpy of Vaporization: 100.72 kJ/mol; (9)Boiling Point: 650.3 °C at 760 mmHg; (10)Vapour Pressure: 8.47E-18 mmHg at 25°C.

3. Structure Descriptors of Bicalutamide
(1)InChI: InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)/t17-/m0/s1;
(2)InChIKey: InChIKey=LKJPYSCBVHEWIU-KRWDZBQOSA-N;
(3)Smiles: c1(c(ccc(c1)NC([C@@](CS(c1ccc(F)cc1)(=O)=O)(C)O)=O)C#N)C(F)(F)F.

4. Toxicity of Bicalutamide

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
dog LD oral > 2gm/kg (2000mg/kg)   Journal of Toxicological Sciences. Vol. 22, Pg. 75, 1997.
mouse LD oral > 2gm/kg (2000mg/kg)   Journal of Toxicological Sciences. Vol. 22, Pg. 75, 1997.
mouse LD50 intraperitoneal > 2gm/kg (2000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 197, 2000.
rabbit LD50 oral > 200mg/kg (200mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 197, 2000.
rat LD oral > 2gm/kg (2000mg/kg)   Journal of Toxicological Sciences. Vol. 22, Pg. 75, 1997.
rat LD50 intraperitoneal > 2gm/kg (2000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 42, Pg. 197, 2000.

5. Safety information of Bicalutamide
Bicalutamide (CAS NO.90357-06-5) is contraindicated, females and children must not be given to any patient who has shown a hypersensitivity reaction to its use. 
Hazard Codes: IrritantXi
Risk Statements: 36/37/38 
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-36
 S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. 
S36:Wear suitable protective clothing.
RIDADR: 3077
HazardClass: 9
PackingGroup: III

6. Uses of Bicalutamide
Bicalutamide is good for the treatment of stage D2 metastatic prostate cancer in combination with a luteinizing hormone-releasing hormone analogue or as a monotherapy.It has also been used in clinical trials for ovarian cancer and in combination with castration.Most advanced prostate cancer patients eventually become resistant to antiandrogen including bicalutamide therapy. Bicalutamide is contraindicated in patients who have shown a hypersensitivity reaction to its use.

7. Production of Bicalutamide
Bicalutamide can be got from Methyl methacrylate. The detailed steps of this reaction is as follows:

Production of Bicalutamide

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 90357-06-5